Comparison Chart Cantargia AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 11:29:54 2024-05-16 am EDT			5-day change	1st Jan Change
3.656 ^SEK	+3.28%		+1.27%	-2.19%

Apr. 17	Cantargia Publishes New Data on the Can10 Antibody, Detailing Its Interaction with IL1RAP and Functional Inhibition	CI
Apr. 10	Cantargia AB Publishes Preclinical Data on the Potential of CAN10 in Systemic Sclerosis in A Leading Scientific Journal	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CANTARGIA AB	Bio Therapeutic Drugs	+3.28%	+1.27%	-2.19%	-28.80%	-80.86%	60.87M